Trial Profile
A Real-World, Observational, Longitudinal Cohort Study Assessing the Drug Survival of Biologic Treatments in Patients with Psoriasis in Sweden
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 May 2018
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary) ; Ustekinumab (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 24 May 2018 New trial record
- 23 May 2018 Results presented at the 23rd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research.